Arix Bioscience plc: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics |
September 30, 2019 | September 2019 Bond Updates |
LONDON, Sept. 30, 2019 /PRNewswire/ -- Arix Bioscience plc ("Arix") (LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it has invested in new portfolio company STipe Therapeutics ("STipe"), a company... |
View more at: https://www.prnewswire.com:443/news-releases/arix-bioscience-plc-arix-co-leads-eur-20-million-series-a-investment-round-in-stipe-therapeutics-300927480.html |
Related News |
|